Proportion dying from Cancer in an acute care setting
Description
Percentage of patients who died from cancer dying in an acute care setting
CBE ID
0214
American Society of Clinical Oncology
Proportion of patients who died from cancer not admitted to hospice
Description
Proportion of patients who died from cancer not admitted to hospice
CBE ID
0215
Proportion of patients who died from cancer with more than one emergency department visit in the last 30 days of life
Description
Proportion of patients who died from cancer with more than one emergency department visit in the last 30 days of life
CBE ID
0211
Proportion with more than one hospitalization in the last 30 days of life
Description
Percentage of patients who died from cancer with more than one hospitalization in the last 30 days of life
CBE ID
0212
RAS gene mutation testing performed for patients with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy
Description
Percentage of adult patients (aged 18 and over) with metastatic colorectal cancer who receive anti-epidermal growth factor receptor monoclonal antibody therapy for whom RAS (KRAS and NRAS) gene mutation testing was performed
CBE ID
1859
Trastuzumab administered to patients with AJCC stage I (T1c) – III human epidermal growth factor receptor 2 (HER2) positive breast cancer who receive adjuvant chemotherapy
Description
Percentage of female patients aged 18 and over with HER2/neu positive invasive breast cancer who are administered trastuzumab
CBE ID
1858